CARDURA® XL 4 mg – 28 Extended-Release Tablets

CARDURA® XL contains 4 mg of doxazosin mesylate in an extended-release formulation designed for once-daily administration. It is used to help manage the symptoms of benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate, by relaxing smooth muscle in the prostate and bladder neck to improve urine flow and reduce urinary symptoms. The extended-release technology provides a controlled release of medication throughout the day, supporting consistent therapeutic effects. Each pack contains 28 tablets and is manufactured to high pharmaceutical quality standards for safety, efficacy, and patient convenience.